RxDoctor Payments Data

Myra Belle Julom, PA

Physician Assistant · Placentia, CANPI 1801597539

Payments from drug & device makers

$665in general payments, 2019–2025

Across 26 payments — averaging $25.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$157
  • Exact Sciences$103
  • Amgen$95
  • GSK$76
  • Pfizer$59
  • Novo Nordisk$41
  • plus $133 from 5 others

What the payments were for

  • Food & beverage$665100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$665 in reported general payments places this provider in the 65th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$5,689
Medicare patients
49
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$47,065
JardianceEmpagliflozin26$27,018
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$25,047
BenicarOlmesartan Medoxomil14$24,348
TrulicityDulaglutide14$19,897
Breo ElliptaFluticasone/Vilanterol17$8,628
Levothyroxine Sodium268$4,184
Atorvastatin Calcium394$3,935
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$3,442
Humulin 70-30Insulin Nph Hum/Reg Insulin Hm12$2,678
BreynaBudesonide/Formoterol Fumarate11$2,621
Wixela InhubFluticasone Propion/Salmeterol15$2,188
Amlodipine Besylate260$1,857
Potassium Chloride41$1,635
Methenamine Hippurate14$1,577

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$59$47,06540 claims
GSKTrelegy Ellipta, Breo Ellipta$76$33,67552 claims
Boehringer IngelheimJardiance$27$27,01826 claims
Lilly USA, LLCTrulicity, Humulin 70-30$39$22,57526 claims
AbbVieSynthroid$23$1,33012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Placentia

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →